High quality data from these systems provides unique insights into protein interactions for better understanding of biological mechanisms, greater productivity and reduced development costs
Biacore International has announced the launch of Biacore A100 and Flexchip systems.
Both systems offer array-based protein interaction analysis.
Biacore says it has responded to the need for increased throughput in protein interaction analysis by introducing these two array-based systems, both monitoring the entire interaction in real time and without the use of labels.
Flexchip was originally acquired by Biacore earlier this year from HTS Biosystems and is now fully integrated into the company's portfolio.
Flexchip is targeted at the explorative research market for simultaneous profiling of a large number of interactions.
Screening of protein populations enables the mapping of biomolecular networks and the selection of interactions of interest for further analysis.
In contrast, Biacore A100 uses parallel analysis of protein panels against multiple samples to achieve new levels of productivity in large-scale functionality studies, compound selection, biotherapeutic development, preclinical and clinical studies.
This system offers the possibility to obtain and interpret large quantities of quantitative data as demanded for applications in proteomics institutes, pharmaceutical and biotechnology companies.
Biacore says both systems give it an 'unrivalled' position for the application of label free, real time protein interaction analysis in the protein array market, which is worth over US$120 million and is forecast to grow to over $540 million by 2008.
Erik Wallden, Biacore's president and CEO, commented: "Once again Biacore is at the forefront in real time protein interaction analysis.
"With these systems we can truly say that Biacore's products offer a comprehensive approach for applications from pure research, drug discovery to clinical studies and beyond.
"These systems also allow Biacore to apply its expertise and reinforce its leading position by bringing protein interaction arrays into the rapidly emerging protein array market".
